Press Release

Press Release

  • (2023-06-30) Aimedbio signs another "ADC Co-development Agreement" with GeneQuantum

  • 20230629183413_1900890_932_561.jpg

    - Aimedbio has previously signed an agreement with GeneQuantum to co-develop AMB302/GQ1011 on April 2022

    - Based on good results, Aimedbio and GeneQuantum decided to sign another ADC co-development agreement to collaborate on a maximum of five ADCs using Aimedbio's antibody development technology and GeneQuantum's linker conjugation technology

    Link to full news:

Contact Us >>